Author
The author works as a Correspondent with BW Businessworld
Healthvista India’s debut on the Indian exchanges will be the first from the $6-billion home healthcare stable
Read More
On Monday, The Union Health Ministry said that it has requested the Indian Computer Emergency Response Team (CERT-In) to look into the CoWIN data breach reported in the media and submit a report adding that an additional internal exercise has also been initiated to review the existing security measures of CoWIN
Read More
India is facing a tough challenge in sourcing donors for stem cell transplants that prove as a saviour for many patients suffering from various types of blood disorders like leukaemia, thalassemia and aplastic anaemia among others. As per reports, India registers over 1,00,000 patients every year who are tackling different blood disorders. Out of this, the doctors say, 10 to 15 per cent of patients end up requiring stem cell transplants which can save their lives in majority of the cases
Read More
Biocon’s MD and CEO, Siddharth Mittal in a post-annual results interaction with BW Healthcare World stated that, “As we move forward, we see a huge potential in peptides. It is a growing segment where the big shift is being seen with companies like Novo Nordisk or Eli Lilly moving their focus from insulins to GLP1 drugs and what used to be USD 20-30 billion insulin market is now actually projected to be over USD 100 billion GLP1 market"
Read More
Ahmedabad-based Indian pharmaceutical major Torrent Pharmaceutical on Tuesday posted its financials for the fourth quarter and full year ending March 31, 2023. The company posted a net profit of Rs 287 crores in the January-March quarter against a net loss of Rs 188 crores recorded in Q4 last year
Read More
Fortis Healthcare one of India's leading healthcare providers on Tuesday announced its audited consolidated financial results for the quarter and year ended 31 March 2023. The healthcare company has registered consolidated revenues of Rs1,643 crores, up by 19.2 per cent YoY in Q4FY23 against Rs 1,378 recorded in Q4FY22
Read More
Bangalore-based pharmaceutical company Biocon on Tuesday announced its consolidated financial results for the fourth quarter that ended 31st March 2023, the company registered a 58.6 per cent rise in its consolidated revenues from operations year on year. The company's consolidated revenue for the March quarter stood at Rs 3,928 crores against Rs 2,476 crores in the same quarter last year
Read More
Divi's Laboratories on Saturday announced its earnings for the fourth quarter and full year FY23. The company posted a drop in its net profits by 64.2 per cent year on year (YoY) in the March quarter to Rs 320 crores down from 894 crores in the same quarter of the previous year
Read More
The fate of non-sugar sweeteners (NSS) or popularly known as sugar-free substitutes might just be changing as the scientific evidence gathering against them suggests that the artificial sweeteners may not be efficacious for many health benefits that they were previously lauded for or which led to their fame
Read More
Gland Pharma on Thursday announced its earnings for the fourth quarter and full year FY23. The company's revenue recorded a slump in Q4FY23 by 29.4 per cent year on year (YoY) to be recorded at Rs 824 crore and by 16.6 per cent for FY23 to Rs 3,856 crore compared with Rs 1,168 crore in Q4FY22 and Rs 4,624 in FY22 respectively
Read More
